. . "Profilaxia pr\u00E9-exposi\u00E7\u00E3o (PrPE ou em sua vers\u00E3o inglesa PrEP) \u00E9 qualquer procedimento m\u00E9dico ou sanit\u00E1rio usado antes da exposi\u00E7\u00E3o a um pat\u00F3geno capaz de provocar uma doen\u00E7a, com o prop\u00F3sito de prevenir, e n\u00E3o tratar ou curar, essa doen\u00E7a; especialmente referido ao de VIH. Trata-se de um procedimento opcional para pessoas s\u00E3s HIV-negativas, mas que t\u00EAm um risco substancial, mais alto que a m\u00E9dia, de contrair uma infec\u00E7\u00E3o por HIV. Na actualidade, o \u00FAnico f\u00E1rmaco recomendado para a profilaxia pr\u00E9-exposi\u00E7\u00E3o do HIV \u00E9 Truvada, uma combina\u00E7\u00E3o de emtricitabina e tenofovir. Conforme os Centros para o Controle e Preven\u00E7\u00E3o de Doen\u00E7as a PPrE pode ser uma poderosa ferramenta de preven\u00E7\u00E3o do VIH ao combinar-se com preservativos e outros m\u00E9todos de preven\u00E7\u00E3o para proporcionar uma protec\u00E7\u00E3o ainda maior que quando se utilizam por separado. No entanto, as pessoas que usam PrEP devem se comprometer a tomar o medicamento todos os dias e manter um rastreamento ao menos a cada 3 meses. PPrE est\u00E1 recomendado para o uso combinado com preservativos, de maneira que cada m\u00E9todo pode compensar os d\u00E9ficits de efic\u00E1cia ocasionais do outro. Existe uma divis\u00E3o social entre o apoio e a oposi\u00E7\u00E3o ao uso da profilaxia pr\u00E9-exposi\u00E7\u00E3o como m\u00E9todo de preven\u00E7\u00E3o da infec\u00E7\u00E3o por VIH. Em fevereiro de 2016 documentou-se o primeiro caso de uma pessoa que, tomando adequadamente a PPrE, contagiou-se de uma cepa multirresistente ao tratamento, seguido por um segundo caso em outubro do mesmo ano."@pt . . . . . "Pre-exposure prophylaxis (PrEP) is the use of medications to prevent the spread of disease in people who have not yet been exposed to a disease-causing agent, usually a virus. The term typically refers to the use of antiviral drugs as a strategy for the prevention of HIV/AIDS. PrEP is one of a number of HIV prevention strategies for people who are HIV negative but who have a higher risk of acquiring HIV, including sexually active adults at increased risk of contracting HIV, people who engage in intravenous drug use (see drug injection), and serodiscordant sexually active couples."@en . . . "\u0627\u0644\u0648\u0642\u0627\u064A\u0629 \u0642\u0628\u0644 \u0627\u0644\u062A\u0639\u0631\u0636 \u0623\u0648 \u0627\u0644\u0627\u062A\u0642\u0627\u0621 \u0642\u0628\u0644 \u0627\u0644\u062A\u0639\u0631\u0636 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: Pre-exposure prophylaxis)\u200F \u0648\u062A\u064F\u0639\u0631\u0641 \u0627\u062E\u062A\u0635\u0627\u0631\u064B\u0627 PrEP\u060C \u0647\u064A \u0627\u0633\u062A\u0639\u0645\u0627\u0644\u064F \u0627\u0644\u0623\u062F\u0648\u064A\u0629 \u0644\u0645\u0646\u0639 \u062D\u062F\u0648\u062B \u0645\u0631\u0636\u064D \u0641\u064A \u0627\u0644\u0623\u0641\u0631\u0627\u062F \u0627\u0644\u0630\u064A\u0646 \u0644\u0645 \u064A\u062A\u0639\u0631\u0636\u0648\u0627 \u0633\u0627\u0628\u0642\u064B\u0627 \u0644\u0644\u0639\u0627\u0645\u0644 \u0627\u0644\u0645\u064F\u0633\u0628\u0628 \u0644\u0644\u0645\u0631\u0636\u060C \u062E\u0635\u0648\u0635\u064B\u0627 \u0627\u0644\u0641\u064A\u0631\u0648\u0633\u0627\u062A. \u064A\u064F\u0633\u062A\u062E\u062F\u0645 \u0627\u0644\u0645\u064F\u0635\u0637\u0644\u062D \u0639\u0627\u062F\u0629\u064B \u0644\u0644\u0625\u0634\u0627\u0631\u0629 \u0625\u0644\u0649 \u0627\u0633\u062A\u0639\u0645\u0627\u0644 \u0627\u0644\u0645\u064F\u062D\u062F\u062F \u0644\u0645\u0636\u0627\u062F\u0627\u062A \u0627\u0644\u0641\u064A\u0631\u0648\u0633\u0627\u062A \u0641\u064A \u0627\u0644\u0648\u0642\u0627\u064A\u0629 \u0645\u0646 \u0641\u064A\u0631\u0648\u0633 \u0646\u0642\u0635 \u0627\u0644\u0645\u0646\u0627\u0639\u0629 \u0627\u0644\u0628\u0634\u0631\u064A\u0629 (\u0627\u0644\u0648\u0642\u0627\u064A\u0629 \u0645\u0646 \u0627\u0644\u0625\u064A\u062F\u0632). \u0625\u0630\u0627 \u0627\u0633\u062A\u064F\u0639\u0645\u0644 \u0627\u0644\u062F\u0648\u0627\u0621 \u0644\u0644\u0648\u0642\u0627\u064A\u0629 \u0642\u0628\u0644 \u0627\u0644\u062A\u0639\u0631\u0636 \u0628\u0627\u0644\u0634\u0643\u0644 \u0627\u0644\u0635\u062D\u064A\u062D\u060C \u0641\u0625\u0646\u0647\u0627 \u062A\u064F\u0638\u0647\u0631 \u0641\u0639\u0627\u0644\u064A\u0629\u064B \u0639\u0627\u0644\u064A\u0629\u064B\u060C \u062D\u064A\u062B\u064F \u062A\u064F\u0642\u0644\u0644 \u062E\u0637\u0631 \u0627\u0644\u0625\u0635\u0627\u0628\u0629 \u0628\u0641\u064A\u0631\u0648\u0633 \u0646\u0642\u0635 \u0627\u0644\u0645\u0646\u0627\u0639\u0629 \u0627\u0644\u0628\u0634\u0631\u064A\u0629 (\u0627\u0644\u0625\u064A\u062F\u0632) \u0628\u062D\u0648\u0627\u0644\u064A 99%."@ar . "67979"^^ . . . "\u66B4\u9732\u524D\u9884\u9632\uFF08\u82F1\u8A9E\uFF1APre-exposure prophylaxis\uFF0C\u7F29\u5199\u4E3APrEP\uFF09\uFF0C\u53C8\u8BD1\u4F5C\u201C\u63A5\u89E6\u524D\u9884\u9632\u201D\uFF0C\u662F\u6307\u5728\u63A5\u89E6\u75C5\u539F\u4F53\u4E4B\u524D\u7528\u836F\u9884\u9632\u75BE\u75C5\u7684\u63AA\u65BD\uFF0C\u7279\u6307\u5728\u63A5\u89E6\u75C5\u539F\u4F53\u4E4B\u524D\u670D\u7528\u6297\u75C5\u6BD2\u836F\u7269\u9884\u9632\u827E\u6ECB\u75C5\u6BD2/\u827E\u6ECB\u75C5\u7684\u624B\u6BB5\uFF0C\u80FD\u6709\u6548\u964D\u4F4E\u9AD8\u5371\u4EBA\u7FA4\u611F\u67D3\u827E\u6ECB\u75C5\u6BD2\u7684\u98CE\u9669\u3002 \u76EE\u524D\u552F\u4E00\u6709\u5065\u5EB7\u7EC4\u7EC7\u63A8\u8350\u7684PrEP\u836F\u7269\u662F\u6069\u66F2\u4ED6\u6EE8/\u66FF\u8BFA\u798F\u97E6\u3002\u5176\u7531\u5409\u5229\u5FB7\u79D1\u5B78\u516C\u53F8\u5F00\u53D1\uFF0C\u542B\u6709\u66FF\u8AFE\u798F\u97CB\u548C\u6069\u66F2\u4ED6\u6FF1\u4E24\u79CD\u836F\u54C1\u3002\u7F8E\u570B\u75BE\u75C5\u63A7\u5236\u8207\u9810\u9632\u4E2D\u5FC3\u79F0\uFF0C\u201CPrEP\u662F\u4E00\u79CD\u6709\u6548\u7684HIV\u9632\u6CBB\u624B\u6BB5\u3002\u5F53\u7ED3\u5408\u5B89\u5168\u5957\u7B49\u9632\u6CBB\u65B9\u6CD5\u4E00\u540C\u4F7F\u7528\uFF0C\u5176\u4FDD\u62A4\u6548\u679C\u66F4\u4F73\u3002\u4E0D\u8FC7PrEP\u7684\u4F7F\u7528\u8005\u5FC5\u987B\u6BCF\u65E5\u670D\u7528\u836F\u7269\uFF0C\u5E76\u6BCF\u4E09\u4E2A\u6708\u62DC\u8BBF\u533B\u751F\uFF0C\u4EE5\u4FBF\u8DDF\u8E2A\u6CBB\u7597\u3002\u201D\u4E16\u754C\u885B\u751F\u7D44\u7E54\uFF08WHO\uFF09\u5EFA\u8B70\u5728\u65B0\u611F\u67D3\u4EBA\u6578\u5927\u65BC\u6BCF\u767E\u4EBA\u5E743\u4EBA\u4EE5\u4E0A\u7684\u65CF\u7FA4\uFF0C\u61C9\u8A72\u5C07PrEP\u4F5C\u70BA\u9810\u9632\u63AA\u65BD\u4E4B\u4E00\u3002 \u53F0\u6E7E\u65BC2016\u5E74\u3001\u4E2D\u56FD\u5927\u9646\u65BC2020\u5E74\u6838\u51C6\u8212\u53D1\u6CF0\u4F5C\u70BAPrEP\u4F7F\u7528\u3002"@zh . "\u66B4\u9732\u524D\u4E88\u9632\u6295\u4E0E\uFF08\u3070\u304F\u308D\u305C\u3093\u3088\u307C\u3046\u3068\u3046\u3084\u304F\u3001\u82F1\u8A9E: Pre-exposure prophylaxis\u3001\u7565\u79F0:PrEP\uFF09\u306F\u3001\u307E\u3060\u75BE\u60A3\u3092\u5F15\u304D\u8D77\u3053\u3059\u7269\u8CEA\u306B\u66B4\u9732\u3055\u308C\u3066\u3044\u306A\u3044\u4EBA\u3005\u306E\u611F\u67D3\u3092\u4E88\u9632\u3059\u308B\u305F\u3081\u306E\u85AC\u306E\u4F7F\u7528\u3067\u3042\u308B\u3002\u3053\u306E\u7528\u8A9E\u306F\u901A\u5E38\u3001\u5F8C\u5929\u6027\u514D\u75AB\u4E0D\u5168\u75C7\u5019\u7FA4\uFF08HIV/AIDS\uFF09\u306E\u4E88\u9632\u306E\u305F\u3081\u306E\u6297HIV\u85AC\u3092\u610F\u5473\u3059\u308B\u3002"@ja . "\u0397 \u03C0\u03C1\u03BF\u03C6\u03CD\u03BB\u03B1\u03BE\u03B7 \u03C0\u03C1\u03B9\u03BD \u03B1\u03C0\u03CC \u03C4\u03B7\u03BD \u03AD\u03BA\u03B8\u03B5\u03C3\u03B7 ( PrEP ) \u03B5\u03AF\u03BD\u03B1\u03B9 \u03C6\u03AC\u03C1\u03BC\u03B1\u03BA\u03B1 \u03C0\u03BF\u03C5 \u03C7\u03C1\u03B7\u03C3\u03B9\u03BC\u03BF\u03C0\u03BF\u03B9\u03BF\u03CD\u03BD\u03C4\u03B1\u03B9 \u03B3\u03B9\u03B1 \u03C4\u03B7\u03BD \u03C0\u03C1\u03CC\u03BB\u03B7\u03C8\u03B7 \u03C4\u03B7\u03C2 \u03B5\u03BE\u03AC\u03C0\u03BB\u03C9\u03C3\u03B7\u03C2 \u03C4\u03B7\u03C2 \u03BD\u03CC\u03C3\u03BF\u03C5 \u03C4\u03BF\u03C5 HIV \u03C3\u03B5 \u03AC\u03C4\u03BF\u03BC\u03B1 \u03C0\u03BF\u03C5 \u03B4\u03B5\u03BD \u03AD\u03C7\u03BF\u03C5\u03BD \u03B1\u03BA\u03CC\u03BC\u03B7 \u03B5\u03BA\u03C4\u03B5\u03B8\u03B5\u03AF \u03C3\u03B5 \u03C0\u03B1\u03C1\u03AC\u03B3\u03BF\u03BD\u03C4\u03B1 \u03C0\u03BF\u03C5 \u03C0\u03C1\u03BF\u03BA\u03B1\u03BB\u03B5\u03AF \u03B1\u03C3\u03B8\u03AD\u03BD\u03B5\u03B9\u03B1, \u03C3\u03C5\u03BD\u03AE\u03B8\u03C9\u03C2 \u03AD\u03BD\u03B1\u03BD \u03B9\u03CC . \u039F \u03CC\u03C1\u03BF\u03C2 \u03B1\u03BD\u03B1\u03C6\u03AD\u03C1\u03B5\u03C4\u03B1\u03B9 \u03C3\u03C5\u03BD\u03AE\u03B8\u03C9\u03C2 \u03C3\u03C4\u03B7\u03BD \u03B5\u03B9\u03B4\u03B9\u03BA\u03AE \u03C7\u03C1\u03AE\u03C3\u03B7 \u03B1\u03BD\u03C4\u03B9\u03B9\u03BA\u03CE\u03BD \u03C6\u03B1\u03C1\u03BC\u03AC\u03BA\u03C9\u03BD \u03C9\u03C2 \u03C3\u03C4\u03C1\u03B1\u03C4\u03B7\u03B3\u03B9\u03BA\u03AE \u03B3\u03B9\u03B1 \u03C4\u03B7\u03BD \u03C0\u03C1\u03CC\u03BB\u03B7\u03C8\u03B7 \u03C4\u03BF\u03C5 HIV / AIDS . \u03A4\u03BF PrEP \u03B5\u03AF\u03BD\u03B1\u03B9 \u03BC\u03AF\u03B1 \u03B1\u03C0\u03CC \u03C4\u03B9\u03C2 \u03C0\u03BF\u03BB\u03BB\u03AD\u03C2 \u03C3\u03C4\u03C1\u03B1\u03C4\u03B7\u03B3\u03B9\u03BA\u03AD\u03C2 \u03C0\u03C1\u03CC\u03BB\u03B7\u03C8\u03B7\u03C2 \u03C4\u03BF\u03C5 HIV \u03B3\u03B9\u03B1 \u03AC\u03C4\u03BF\u03BC\u03B1 \u03C0\u03BF\u03C5 \u03B5\u03AF\u03BD\u03B1\u03B9 \u03B1\u03C1\u03BD\u03B7\u03C4\u03B9\u03BA\u03AC \u03C3\u03C4\u03BF\u03BD HIV, \u03B1\u03BB\u03BB\u03AC \u03AD\u03C7\u03BF\u03C5\u03BD \u03B5\u03C0\u03AF\u03C3\u03B7\u03C2 \u03C5\u03C8\u03B7\u03BB\u03CC\u03C4\u03B5\u03C1\u03BF \u03BA\u03AF\u03BD\u03B4\u03C5\u03BD\u03BF \u03BD\u03B1 \u03C0\u03C1\u03BF\u03C3\u03B2\u03BB\u03B7\u03B8\u03BF\u03CD\u03BD \u03B1\u03C0\u03CC \u03C4\u03BF\u03BD \u03B9\u03CC HIV, \u03C3\u03C5\u03BC\u03C0\u03B5\u03C1\u03B9\u03BB\u03B1\u03BC\u03B2\u03B1\u03BD\u03BF\u03BC\u03AD\u03BD\u03C9\u03BD \u03C4\u03C9\u03BD \u03C3\u03B5\u03BE\u03BF\u03C5\u03B1\u03BB\u03B9\u03BA\u03AC \u03B5\u03BD\u03B5\u03C1\u03B3\u03CE\u03BD \u03B5\u03BD\u03B7\u03BB\u03AF\u03BA\u03C9\u03BD \u03BC\u03B5 \u03B1\u03C5\u03BE\u03B7\u03BC\u03AD\u03BD\u03BF \u03BA\u03AF\u03BD\u03B4\u03C5\u03BD\u03BF HIV, \u03C4\u03C9\u03BD \u03B1\u03C4\u03CC\u03BC\u03C9\u03BD \u03C0\u03BF\u03C5 \u03B5\u03BC\u03C0\u03BB\u03AD\u03BA\u03BF\u03BD\u03C4\u03B1\u03B9 \u03C3\u03C4\u03B7 \u03C7\u03C1\u03AE\u03C3\u03B7 \u03B5\u03BD\u03AD\u03C3\u03B9\u03BC\u03C9\u03BD \u03BD\u03B1\u03C1\u03BA\u03C9\u03C4\u03B9\u03BA\u03CE\u03BD (\u03B2\u03BB. \u0388\u03BD\u03B5\u03C3\u03B7 \u03BD\u03B1\u03C1\u03BA\u03C9\u03C4\u03B9\u03BA\u03CE\u03BD ), \u03BA\u03B1\u03B9 \u03C3\u03B5\u03C1\u03BF\u03B4\u03B9\u03B1\u03C6\u03BF\u03C1\u03B9\u03BA\u03AC \u03C3\u03B5\u03BE\u03BF\u03C5\u03B1\u03BB\u03B9\u03BA\u03AC \u03B5\u03BD\u03B5\u03C1\u03B3\u03AC \u03B6\u03B5\u03C5\u03B3\u03AC\u03C1\u03B9\u03B1"@el . . . . "\u0627\u0644\u0648\u0642\u0627\u064A\u0629 \u0642\u0628\u0644 \u0627\u0644\u062A\u0639\u0631\u0636 \u0623\u0648 \u0627\u0644\u0627\u062A\u0642\u0627\u0621 \u0642\u0628\u0644 \u0627\u0644\u062A\u0639\u0631\u0636 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: Pre-exposure prophylaxis)\u200F \u0648\u062A\u064F\u0639\u0631\u0641 \u0627\u062E\u062A\u0635\u0627\u0631\u064B\u0627 PrEP\u060C \u0647\u064A \u0627\u0633\u062A\u0639\u0645\u0627\u0644\u064F \u0627\u0644\u0623\u062F\u0648\u064A\u0629 \u0644\u0645\u0646\u0639 \u062D\u062F\u0648\u062B \u0645\u0631\u0636\u064D \u0641\u064A \u0627\u0644\u0623\u0641\u0631\u0627\u062F \u0627\u0644\u0630\u064A\u0646 \u0644\u0645 \u064A\u062A\u0639\u0631\u0636\u0648\u0627 \u0633\u0627\u0628\u0642\u064B\u0627 \u0644\u0644\u0639\u0627\u0645\u0644 \u0627\u0644\u0645\u064F\u0633\u0628\u0628 \u0644\u0644\u0645\u0631\u0636\u060C \u062E\u0635\u0648\u0635\u064B\u0627 \u0627\u0644\u0641\u064A\u0631\u0648\u0633\u0627\u062A. \u064A\u064F\u0633\u062A\u062E\u062F\u0645 \u0627\u0644\u0645\u064F\u0635\u0637\u0644\u062D \u0639\u0627\u062F\u0629\u064B \u0644\u0644\u0625\u0634\u0627\u0631\u0629 \u0625\u0644\u0649 \u0627\u0633\u062A\u0639\u0645\u0627\u0644 \u0627\u0644\u0645\u064F\u062D\u062F\u062F \u0644\u0645\u0636\u0627\u062F\u0627\u062A \u0627\u0644\u0641\u064A\u0631\u0648\u0633\u0627\u062A \u0641\u064A \u0627\u0644\u0648\u0642\u0627\u064A\u0629 \u0645\u0646 \u0641\u064A\u0631\u0648\u0633 \u0646\u0642\u0635 \u0627\u0644\u0645\u0646\u0627\u0639\u0629 \u0627\u0644\u0628\u0634\u0631\u064A\u0629 (\u0627\u0644\u0648\u0642\u0627\u064A\u0629 \u0645\u0646 \u0627\u0644\u0625\u064A\u062F\u0632). \u062A\u064F\u0639\u062A\u0628\u0631 \u0627\u0644\u0648\u0642\u0627\u064A\u0629 \u0642\u0628\u0644 \u0627\u0644\u062A\u0639\u0631\u0636 \u0648\u0627\u062D\u062F\u0629\u064B \u0645\u0646 \u0625\u0633\u062A\u0631\u0627\u062A\u064A\u062C\u0627\u062A \u0627\u0644\u0648\u0642\u0627\u064A\u0629 \u0645\u0646 \u0641\u064A\u0631\u0648\u0633 \u0627\u0644\u0639\u0648\u0632 \u0627\u0644\u0645\u0646\u0627\u0639\u064A \u0627\u0644\u0628\u0634\u0631\u064A (\u0641\u064A\u0631\u0648\u0633 \u0627\u0644\u0625\u064A\u062F\u0632) \u0641\u064A \u0627\u0644\u0623\u0641\u0631\u0627\u062F \u0633\u0644\u0628\u064A\u064A \u0648\u062C\u0648\u062F \u0627\u0644\u0641\u064A\u0631\u0648\u0633\u060C \u0648\u0623\u064A\u0636\u064B\u0627 \u0641\u064A \u0627\u0644\u0623\u0634\u062E\u0627\u0635 \u0627\u0644\u0630\u064A\u0646 \u0644\u062F\u064A\u0647\u0645 \u062E\u0637\u0631\u064C \u0645\u064F\u062A\u0632\u0627\u064A\u062F\u064C (\u0623\u0639\u0644\u0649 \u0645\u0646 \u0627\u0644\u0645\u062A\u0648\u0633\u0637) \u0644\u0644\u0625\u0635\u0627\u0628\u0629 \u0628\u0641\u064A\u0631\u0648\u0633 \u0627\u0644\u0639\u0648\u0632 \u0627\u0644\u0645\u0646\u0627\u0639\u064A \u0627\u0644\u0628\u0634\u0631\u064A\u060C \u0645\u062B\u0644 \u0627\u0644\u0628\u0627\u0644\u063A\u064A\u0646 \u0627\u0644\u0646\u064E\u0634\u0637\u064A\u0646 \u062C\u0646\u0633\u064A\u064B\u0627 (\u0645\u062B\u0644 )\u060C \u0648\u0627\u0644\u0623\u0641\u0631\u0627\u062F \u0627\u0644\u0630\u064A\u0646 \u064A\u062A\u0639\u0627\u0637\u0648\u0646 \u0627\u0644\u0645\u064F\u062E\u062F\u0631\u0627\u062A \u060C \u0648\u0627\u0644\u0632\u0648\u062C\u0627\u0646 \u0627\u0644\u0646\u0634\u0637\u0627\u0646 \u062C\u0646\u0633\u064A\u064B\u0627. \u0635\u064F\u0645\u0645\u062A \u0627\u0644\u0648\u0642\u0627\u064A\u0629 \u0642\u0628\u0644 \u0627\u0644\u062A\u0639\u0631\u0636 \u0644\u0627\u0633\u062A\u0639\u0645\u0627\u0644\u0647\u0627 \u0645\u0639 \u0623\u0633\u0627\u0644\u064A\u0628 \u062A\u0642\u0644\u064A\u0644 \u0627\u0644\u062E\u0637\u0631 \u0627\u0644\u0623\u064F\u062E\u0631\u0649 \u0645\u062B\u0644 \u0627\u0644\u0639\u0648\u0627\u0632\u0644 \u0627\u0644\u0630\u0643\u0631\u064A\u0629\u061B \u0648\u0630\u0644\u0643 \u0644\u0623\u0646\u0647 \u0644\u0627 \u0632\u0627\u0644 \u064A\u0648\u062C\u062F \u0628\u0639\u0636 \u0627\u0644\u062E\u0637\u0631 \u0644\u0644\u0625\u0635\u0627\u0628\u0629 \u0628\u0627\u0644\u0625\u064A\u062F\u0632 \u0645\u0639 \u0627\u0644\u0648\u0642\u0627\u064A\u0629 \u0642\u0628\u0644 \u0627\u0644\u062A\u0639\u0631\u0636\u060C \u062E\u0635\u0648\u0635\u064B\u0627 \u0641\u064A \u0627\u0644\u0623\u0641\u0631\u0627\u062F \u0627\u0644\u0630\u064A\u0646 \u0644\u0627 \u064A\u0623\u062E\u0630\u0648\u0646 \u062F\u0648\u0627\u0621 \u0627\u0644\u0648\u0642\u0627\u064A\u0629 \u0628\u0627\u0633\u062A\u0645\u0631\u0627\u0631\u060C \u0643\u0645\u0627 \u0623\u0646\u064E\u0651 \u0627\u0644\u0623\u0641\u0631\u0627\u062F \u0644\u0627 \u0632\u0627\u0644\u0648\u0627 \u0645\u064F\u0639\u0631\u0636\u064A\u0646 \u0644\u0644\u0625\u0635\u0627\u0628\u0629 \u0628\u0627\u0644\u0623\u0646\u0648\u0627\u0639 \u0627\u0644\u0623\u062E\u0631\u0649 \u0645\u0646 \u0627\u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0645\u0646\u0642\u0648\u0644\u0629 \u062C\u0646\u0633\u064A\u064B\u0627. \u0627\u0639\u062A\u0628\u0627\u0631\u064B\u0627 \u0645\u0646 2019 \u0623\u0635\u0628\u062D\u062A \u0645\u0646\u0638\u0645\u0629 \u0627\u0644\u0635\u062D\u0629 \u0627\u0644\u0639\u0627\u0644\u0645\u064A\u0629 (WHO) \u062A\u064F\u0648\u0635\u064A \u0628\u062F\u0648\u0627\u0626\u064A\u0646 \u0644\u0627\u0633\u062A\u0639\u0645\u0627\u0644 \u0641\u064A \u0627\u0644\u0648\u0642\u0627\u064A\u0629 \u0642\u0628\u0644 \u0627\u0644\u062A\u0639\u0631\u0636: \u062E\u0644\u064A\u0637 \u062A\u064A\u0646\u0648\u0641\u0648\u0641\u064A\u0631/\u0625\u0645\u062A\u0631\u064A\u0633\u064A\u062A\u0627\u0628\u064A\u0646\u060C \u0648\u0630\u0644\u0643 \u0639\u0644\u0649 \u0634\u0643\u0644 \u062A\u0631\u0648\u0641\u0627\u062F\u0627 (Truvada)\u060C \u0648\u0647\u0648 \u0627\u0644\u0627\u0633\u0645 \u0627\u0644\u062A\u062C\u0627\u0631\u064A \u0644\u0645\u0631\u0643\u0628 \u063A\u064A\u0644\u064A\u0627\u062F \u0633\u0627\u064A\u0646\u0633\u0632 \u0627\u0644\u062F\u0648\u0627\u0626\u064A\u060C \u0623\u0648 \u062A\u064A\u0646\u0648\u0641\u0648\u0641\u064A\u0631/\u0644\u0627\u0645\u064A\u0641\u0648\u062F\u064A\u0646. \u0641\u064A \u0623\u0643\u062A\u0648\u0628\u0631 2019\u060C \u0648\u0627\u0641\u0642\u062A \u0625\u062F\u0627\u0631\u0629 \u0627\u0644\u063A\u0630\u0627\u0621 \u0648\u0627\u0644\u062F\u0648\u0627\u0621 \u0627\u0644\u0623\u0645\u0631\u064A\u0643\u064A\u0629 \u0639\u0644\u0649 \u062F\u0648\u0627\u0621 \u062F\u064A\u0633\u0643\u0648\u0641\u064A (Descovy) \u0648\u0647\u0648 \u062E\u0644\u064A\u0637 \u0625\u0645\u062A\u0631\u064A\u0633\u064A\u062A\u0627\u0628\u064A\u0646/\u062A\u064A\u0646\u0648\u0641\u0648\u0641\u064A\u0631 \u0623\u0644\u0627\u0641\u064A\u0646\u0627\u0645\u064A\u062F \u0644\u0627\u0633\u062A\u0639\u0645\u0627\u0644\u0647 \u0641\u064A \u0627\u0644\u0648\u0642\u0627\u064A\u0629 \u0642\u0628\u0644 \u0627\u0644\u062A\u0639\u0631\u0636\u060C \u0645\u0639 \u062A\u0631\u0648\u0641\u0627\u062F\u0627\u060C \u0648\u0630\u0644\u0643 \u064A\u0645\u0646\u062D \u0646\u0641\u0633 \u0627\u0644\u0642\u062F\u0631 \u0645\u0646 \u0627\u0644\u062D\u0645\u0627\u064A\u0629. \u0625\u0630\u0627 \u0627\u0633\u062A\u064F\u0639\u0645\u0644 \u0627\u0644\u062F\u0648\u0627\u0621 \u0644\u0644\u0648\u0642\u0627\u064A\u0629 \u0642\u0628\u0644 \u0627\u0644\u062A\u0639\u0631\u0636 \u0628\u0627\u0644\u0634\u0643\u0644 \u0627\u0644\u0635\u062D\u064A\u062D\u060C \u0641\u0625\u0646\u0647\u0627 \u062A\u064F\u0638\u0647\u0631 \u0641\u0639\u0627\u0644\u064A\u0629\u064B \u0639\u0627\u0644\u064A\u0629\u064B\u060C \u062D\u064A\u062B\u064F \u062A\u064F\u0642\u0644\u0644 \u062E\u0637\u0631 \u0627\u0644\u0625\u0635\u0627\u0628\u0629 \u0628\u0641\u064A\u0631\u0648\u0633 \u0646\u0642\u0635 \u0627\u0644\u0645\u0646\u0627\u0639\u0629 \u0627\u0644\u0628\u0634\u0631\u064A\u0629 (\u0627\u0644\u0625\u064A\u062F\u0632) \u0628\u062D\u0648\u0627\u0644\u064A 99%."@ar . . . "La profilaxis preexposici\u00F3n (acr\u00F3nimo PPrE o en su versi\u00F3n inglesa PrEP) se refiere a la administraci\u00F3n de f\u00E1rmacos antirretrovirales de forma continuada a personas seronegativas para VIH con riesgo sustancial, superior al promedio, de contraer una infecci\u00F3n por VIH.\u200B Si una persona est\u00E1 tomando PPrE y se expone al semen, l\u00EDquido pre-seminal o fluidos vaginales de una persona con VIH, el medicamento antirretroviral ayuda a prevenir que el virus infecte las c\u00E9lulas del sistema inmunol\u00F3gico y as\u00ED evita que se establezca la infecci\u00F3n por VIH.\u200B"@es . . . . . "Is \u00E9ard at\u00E1 i gceist leis an gcl\u00E1r PrEP n\u00F3 pr\u00F3ifiolacsas r\u00E9amhnochta (n\u00F3 Truvada) n\u00E1 \u00FAs\u00E1id r\u00E9amhchoisctheach a bhaint as c\u00F3gais frithv\u00EDreasacha chun ionfhabht\u00FA VEID a chosc."@ga . . . . . . . . "\u041F\u0440\u0435\u0434\u044D\u043A\u0441\u043F\u043E\u0437\u0438\u0446\u0438\u043E\u043D\u043D\u0430\u044F \u0438\u043B\u0438 \u0434\u043E\u043A\u043E\u043D\u0442\u0430\u043A\u0442\u043D\u0430\u044F \u043F\u0440\u043E\u0444\u0438\u043B\u0430\u043A\u0442\u0438\u043A\u0430 \u0412\u0418\u0427, \u041F\u0440\u0415\u041F (\u041F\u0440\u042D\u041F \u0432 \u043D\u0435\u043A\u043E\u0442\u043E\u0440\u044B\u0445 \u0440\u0443\u0441\u0441\u043A\u043E\u044F\u0437\u044B\u0447\u043D\u044B\u0445 \u0438\u0441\u0442\u043E\u0447\u043D\u0438\u043A\u0430\u0445) \u0438\u043B\u0438 \u0414\u041A\u041F (\u0430\u043D\u0433\u043B. Pre-exposure prophylaxis, PrEP) \u2014 \u043F\u0440\u043E\u0444\u0438\u043B\u0430\u043A\u0442\u0438\u0447\u0435\u0441\u043A\u0438\u0439 \u043F\u0440\u0438\u0451\u043C \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u043E\u0432 \u0432\u044B\u0441\u043E\u043A\u043E\u0430\u043A\u0442\u0438\u0432\u043D\u043E\u0439 \u0430\u043D\u0442\u0438\u0440\u0435\u0442\u0440\u043E\u0432\u0438\u0440\u0443\u0441\u043D\u043E\u0439 \u0442\u0435\u0440\u0430\u043F\u0438\u0438 \u043B\u044E\u0434\u044C\u043C\u0438, \u043D\u0435 \u0438\u043C\u0435\u044E\u0449\u0438\u043C\u0438 \u0412\u0418\u0427, \u0441 \u0446\u0435\u043B\u044C\u044E \u0441\u043D\u0438\u0436\u0435\u043D\u0438\u044F \u0440\u0438\u0441\u043A\u0430 \u0432\u043E\u0437\u043C\u043E\u0436\u043D\u043E\u0433\u043E \u0437\u0430\u0440\u0430\u0436\u0435\u043D\u0438\u044F \u044D\u0442\u0438\u043C \u0432\u0438\u0440\u0443\u0441\u043E\u043C."@ru . . . "\u66B4\u9732\u524D\u4E88\u9632\u6295\u4E0E"@ja . . "Profilaksis prapajanan"@in . "La profilaxi preexposici\u00F3 (acr\u00F2nim PPrE o en la seva versi\u00F3 anglesa PrEP) es refereix a l'administraci\u00F3 de medicaments de forma di\u00E0ria amb la finalitat d'evitar el contagi d'una possible infecci\u00F3, especialment la del VIH. Un dels ingredients actius de la preparaci\u00F3 \u00E9s el fumarat de disoproxil de tenofovir, que \u00E9s un an\u00E0leg de nucle\u00F2tid que inhibeix de la transcriptasa inversa i bloqueja efica\u00E7ment la incorporaci\u00F3 del material gen\u00E8tic del VIH en el genoma de l'hoste, i per tant, evita la infecci\u00F3 per VIH. A finals del 2019 es va iniciar la possibilitat de la PPrE a Catalunya."@ca . . "PrEP, afkorting van Pre-Expositie Profylaxe (of vaak ook Engels pre-exposure prophylaxis), is het gebruik van hiv-remmers om een hiv-infectie te voorkomen. De naam verwijst naar preventie (profylaxe) v\u00F3\u00F3r blootstelling aan een mogelijk risico (pre-expositie). Deze preventiemethode is bedoeld voor mensen die geen hiv hebben, maar wel een verhoogd risico lopen. De effectiviteit van PrEP is bijzonder hoog; studies tonen aan dat het bij consistent gebruik het risico op hiv-overdracht met meer dan 99% vermindert. PrEP is niet te verwarren met PEP (Post-Expositie Profylaxe), dat wordt ingezet om de kans op infectie te verkleinen n\u00E1dat men risico heeft gelopen."@nl . "\u041F\u0435\u0440\u0435\u0434\u0435\u043A\u0441\u043F\u043E\u0437\u0438\u0446\u0456\u0439\u043D\u0430 \u0430\u0431\u043E \u0434\u043E\u043A\u043E\u043D\u0442\u0430\u043A\u0442\u043D\u0430 \u043F\u0440\u043E\u0444\u0456\u043B\u0430\u043A\u0442\u0438\u043A\u0430 \u0412\u0406\u041B, \u041F\u0440\u0415\u041F \u0430\u0431\u043E \u0414\u041A\u041F (\u0430\u043D\u0433\u043B. Pre-exposure prophylaxis, PrEP) \u2014 \u043F\u0440\u043E\u0444\u0456\u043B\u0430\u043A\u0442\u0438\u0447\u043D\u0438\u0439 \u043F\u0440\u0438\u0439\u043E\u043C \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0456\u0432 \u0432\u0438\u0441\u043E\u043A\u043E\u0430\u043A\u0442\u0438\u0432\u043D\u043E\u0457 \u0430\u043D\u0442\u0438\u0440\u0435\u0442\u0440\u043E\u0432\u0456\u0440\u0443\u0441\u043D\u043E\u0457 \u0442\u0435\u0440\u0430\u043F\u0456\u0457 \u043B\u044E\u0434\u044C\u043C\u0438, \u044F\u043A\u0456 \u043D\u0435 \u043C\u0430\u044E\u0442\u044C \u0412\u0406\u041B, \u0437 \u043C\u0435\u0442\u043E\u044E \u0437\u043D\u0438\u0436\u0435\u043D\u043D\u044F \u0440\u0438\u0437\u0438\u043A\u0443 \u043C\u043E\u0436\u043B\u0438\u0432\u043E\u0433\u043E \u0437\u0430\u0440\u0430\u0436\u0435\u043D\u043D\u044F \u0446\u0438\u043C \u0432\u0456\u0440\u0443\u0441\u043E\u043C. \u041F\u0440\u043E\u0432\u0435\u0434\u0435\u043D\u0456 \u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0456 \u0434\u043E\u0441\u043B\u0456\u0434\u0436\u0435\u043D\u043D\u044F \u043F\u043E\u043A\u0430\u0437\u0430\u043B\u0438, \u0449\u043E \u0432\u0438\u043A\u043E\u0440\u0438\u0441\u0442\u0430\u043D\u043D\u044F \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0456\u0432 \u0432\u0438\u0441\u043E\u043A\u043E\u0430\u043A\u0442\u0438\u0432\u043D\u043E\u0457 \u0430\u043D\u0442\u0438\u0440\u0435\u0442\u0440\u043E\u0432\u0456\u0440\u0443\u0441\u043D\u043E\u0457 \u0442\u0435\u0440\u0430\u043F\u0456\u0457 \u0434\u043B\u044F \u043F\u0440\u043E\u0444\u0456\u043B\u0430\u043A\u0442\u0438\u043A\u0438 \u0412\u0406\u041B \u0445\u043E\u0447\u0430 \u0456 \u0437\u043D\u0430\u0447\u043D\u043E \u0437\u043D\u0438\u0436\u0443\u0454 \u0440\u0438\u0437\u0438\u043A \u0437\u0430\u0440\u0430\u0436\u0435\u043D\u043D\u044F, \u0430\u043B\u0435 \u043D\u0435 \u0434\u0430\u044E\u0442\u044C \u043F\u043E\u0432\u043D\u043E\u0457 \u0433\u0430\u0440\u0430\u043D\u0442\u0456\u0457 \u0437\u0430\u0445\u0438\u0441\u0442\u0443 \u0432\u0456\u0434 \u0412\u0406\u041B. \u0404\u0434\u0438\u043D\u0438\u043C \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u043E\u043C, \u0434\u043E\u0437\u0432\u043E\u043B\u0435\u043D\u0438\u043C \u0434\u043B\u044F \u043F\u0440\u0435\u0434\u0435\u043A\u0441\u043F\u043E\u0437\u0438\u0446\u0456\u0439\u043D\u043E\u0457 \u043F\u0440\u043E\u0444\u0456\u043B\u0430\u043A\u0442\u0438\u043A\u0438 \u0412\u0406\u041B, \u0432 \u0434\u0430\u043D\u0438\u0439 \u0447\u0430\u0441 \u0454 Truvada."@uk . . . . . . . . "PrEP"@nl . . . . . . . . "\u041F\u0435\u0440\u0435\u0434\u0435\u043A\u0441\u043F\u043E\u0437\u0438\u0446\u0456\u0439\u043D\u0430 \u043F\u0440\u043E\u0444\u0456\u043B\u0430\u043A\u0442\u0438\u043A\u0430 \u0412\u0406\u041B"@uk . "Pr\u00F3ifiolacsas r\u00E9amhnochta (PrEP)"@ga . . . "La prophylaxie pr\u00E9-exposition, abr\u00E9g\u00E9 PrEP (de l'anglais pre-exposure prophylaxis) est un traitement m\u00E9dicamenteux qui emp\u00EAche l'infection par le virus du sida chez des personnes s\u00E9ron\u00E9gatives. Le m\u00E9dicament utilise la combinaison de deux antir\u00E9troviraux tenofovir/emtricitabine. Initialement, seul le m\u00E9dicament Truvada commercialis\u00E9 par Gilead Sciences pouvait \u00EAtre utilis\u00E9 dans le cadre de la PrEP. Le traitement doit \u00E9galement faire l'objet d'un suivi m\u00E9dical r\u00E9gulier."@fr . . . "\u041F\u0440\u0435\u0434\u044D\u043A\u0441\u043F\u043E\u0437\u0438\u0446\u0438\u043E\u043D\u043D\u0430\u044F \u043F\u0440\u043E\u0444\u0438\u043B\u0430\u043A\u0442\u0438\u043A\u0430 \u0412\u0418\u0427"@ru . . . . "\uB178\uCD9C\uC804 \uC608\uBC29\uC694\uBC95(Pre-exposure prophylaxis, PrEP)\uB294 \uC9C8\uBCD1 \uC720\uBC1C \uBB3C\uC9C8(\uC77C\uBC18\uC801\uC73C\uB85C \uBC14\uC774\uB7EC\uC2A4)\uC5D0 \uC544\uC9C1 \uB178\uCD9C\uB418\uC9C0 \uC54A\uC740 \uC0AC\uB78C\uB4E4\uC758 \uC9C8\uBCD1 \uD655\uC0B0\uC744 \uC608\uBC29\uD558\uAE30 \uC704\uD574 \uC57D\uBB3C\uC744 \uC0AC\uC6A9\uD558\uB294 \uAC83\uC744 \uC758\uBBF8\uD55C\uB2E4. \uC989, \uC77C\uBC18\uC801\uC73C\uB85C \uD56D\uBC14\uC774\uB7EC\uC2A4 \uC57D\uBB3C\uC744 HIV/AIDS \uC608\uBC29\uC744 \uC704\uD574 \uC0AC\uC6A9\uD558\uB294 \uAC83\uC744 \uC758\uBBF8\uD55C\uB2E4. PrEP\uB294 HIV \uC608\uBC29\uC804\uB7B5 \uC911 \uD558\uB098\uB85C \uC131\uC801(sexually)\uC73C\uB85C \uD65C\uB3D9\uC801\uC778 \uC131\uC778, \uC8FC\uC0AC \uC57D\uBB3C \uC0AC\uC6A9\uC5D0 \uAD00\uC5EC\uD558\uB294 \uC0AC\uB78C\uB4E4(\uC57D\uBB3C \uC8FC\uC0AC \uCC38\uC870), \uD55C \uD30C\uD2B8\uB108\uB9CC HIV\uC5D0 \uAC10\uC5FC\uB418\uACE0 \uB2E4\uB978 \uD30C\uD2B8\uB108\uB294 \uAC10\uC5FC\uB418\uC9C0 \uC54A\uC740 \uD608\uCCAD\uD559\uC801\uC73C\uB85C \uBD88\uC77C\uCE58\uD558\uB294 \uC0AC\uB78C\uC744 \uD3EC\uD568\uD558\uC5EC HIV \uC74C\uC131\uC774\uC9C0\uB9CC HIV\uC5D0 \uAC78\uB9B4 \uC704\uD5D8\uC774 \uB192\uC740 \uC0AC\uB78C\uB4E4\uC744 \uC704\uD55C \uAC83\uC774\uB2E4. PrEP\uB294 \uC6D0\uB798 \uACC4\uD68D\uC5D0 \uB9DE\uAC8C \uC801\uC808\uD788 \uC0AC\uC6A9\uB420 \uC2DC, HIV\uC5D0 \uAC10\uC5FC\uB418\uB294 \uC704\uD5D8\uC774 99%\uAE4C\uC9C0 \uAC10\uC18C\uD560 \uC815\uB3C4\uB85C \uB9E4\uC6B0 \uD6A8\uACFC\uC801\uC774\uB2E4. 2019\uB144 \uAE30\uC900, \uC138\uACC4\uBCF4\uAC74\uAE30\uAD6C(WHO)\uB294 PrEP\uB97C \uC704\uD574 \uB450 \uAC00\uC9C0 \uC57D\uBB3C( \uC5E0\uD2B8\uB9AC\uC2DC\uD0C0\uBE48/\uD14C\uB178\uD3EC\uBE44\uB974 \uB514\uC18C\uD504\uB85D\uC2E4 \uB610\uB294 \uB77C\uBBF8\uBD80\uB518/\uD14C\uB178\uD3EC\uBE44\uB974 \uB514\uC18C\uD504\uB85D\uC2E4) \uC870\uD569\uC744 \uC0AC\uC6A9\uD560 \uAC83\uC744 \uAD8C\uACE0\uD588\uB2E4. 2019\uB144 10\uC6D4, \uBBF8\uAD6D \uC2DD\uD488\uC758\uC57D\uAD6D(FDA)\uC5D0\uC11C\uB294 \uD2B8\uB8E8\uBC14\uB2E4(\uC5E0\uD2B8\uB9AC\uC2DC\uD0C0\uBE48/\uD14C\uB178\uD3EC\uBE44\uB974 \uB514\uC18C\uD504\uB85D\uC2E4\uC758 \uC0C1\uD488\uBA85)\uC5D0 \uB354\uD574 \uC5E0\uD2B8\uB9AC\uC2DC\uD0C0\uBE48/\uD14C\uB178\uD3EC\uBE44\uB974 \uC54C\uB77C\uD398\uB098\uB9C8\uC774\uB4DC(\uC0C1\uD488\uBA85 \uB370\uC2A4\uCF54\uBE44)\uC758 \uC0AC\uC6A9\uC744 \uD5C8\uAC00\uD588\uC73C\uBA70, \uB458\uC740 \uBE44\uC2B7\uD55C \uC815\uB3C4\uC758 HIV\uC5D0 \uB300\uD55C \uBCF4\uD638 \uD6A8\uACFC\uB97C \uBCF4\uC778\uB2E4."@ko . . . "La profilassi pre-esposizione (abbreviata in PrEP) \u00E8 una strategia di profilassi, che consiste nell'uso di farmaci per prevenire una malattia in persone che non sono ancora state esposte all'agente che la causa. Il termine si riferisce all'uso di farmaci antiretrovirali come strategia per la prevenzione dell'HIV/AIDS."@it . "Profilaksis prapajanan (bahasa Inggris: Pre-exposure prophylaxis, disingkat PrEP) adalah penggunaan obat-obatan untuk mencegah penyakit pada orang yang belum pernah terpapar dengan agen penyebab penyakit tersebut. Istilah ini khususnya mengacu kepada penggunaan obat-obatan antiretroviral sebagai strategi ."@in . "Prophylaxie pr\u00E9-exposition"@fr . . . . . "Pr\u00E4expositionsprophylaxe"@de . . "La profilaxi preexposici\u00F3 (acr\u00F2nim PPrE o en la seva versi\u00F3 anglesa PrEP) es refereix a l'administraci\u00F3 de medicaments de forma di\u00E0ria amb la finalitat d'evitar el contagi d'una possible infecci\u00F3, especialment la del VIH. Es tracta d'un tractament antiretroviral opcional per a persones sanes VIH-negatives, per\u00F2 que tenen un risc substancial m\u00E9s alt que la mitjana de contreure una infecci\u00F3 pel VIH. El m\u00E9s assajat \u00E9s una combinaci\u00F3 d' i (Truvada\u00AE). Segons els Centres per al Control i Prevenci\u00F3 de Malalties, la PPrE pot ser una poderosa eina de prevenci\u00F3 del VIH en combinaci\u00F3 amb preservatius i altres m\u00E8todes de prevenci\u00F3 per proporcionar una protecci\u00F3 encara major que quan s'utilitzen per separat. No obstant aix\u00F2, les persones que usen PrEP han de comprometre's a prendre el medicament tots els dies i mantenir un seguiment almenys cada tres mesos. Un dels ingredients actius de la preparaci\u00F3 \u00E9s el fumarat de disoproxil de tenofovir, que \u00E9s un an\u00E0leg de nucle\u00F2tid que inhibeix de la transcriptasa inversa i bloqueja efica\u00E7ment la incorporaci\u00F3 del material gen\u00E8tic del VIH en el genoma de l'hoste, i per tant, evita la infecci\u00F3 per VIH. PPrE est\u00E0 recomanat per a l'\u00FAs combinat amb preservatius, de manera que cada m\u00E8tode pot compensar els d\u00E8ficits d'efic\u00E0cia ocasionals de l'altre. Existeix una divisi\u00F3 social entre el suport i l'oposici\u00F3 a l'\u00FAs de la profilaxi preexposici\u00F3 com a m\u00E8tode de prevenci\u00F3 de la infecci\u00F3 per VIH. El 2016 es van documentar els dos primers casos de persones que prenent adequadament la PPrE es van contagiar d'una soca resistent al tractament. A finals del 2019 es va iniciar la possibilitat de la PPrE a Catalunya."@ca . . . . "Pre-exposure prophylaxis (PrEP) is the use of medications to prevent the spread of disease in people who have not yet been exposed to a disease-causing agent, usually a virus. The term typically refers to the use of antiviral drugs as a strategy for the prevention of HIV/AIDS. PrEP is one of a number of HIV prevention strategies for people who are HIV negative but who have a higher risk of acquiring HIV, including sexually active adults at increased risk of contracting HIV, people who engage in intravenous drug use (see drug injection), and serodiscordant sexually active couples. When used as directed, PrEP has been shown to be highly effective, reducing the risk of acquiring HIV by up to 99%. As of 2019, the World Health Organization (WHO) recommends two drug combinations for the use as PrEP for HIV/AIDS: the combination of tenofovir disoproxil and emtricitabine (Truvada), or the combination of tenofovir disoproxil and lamivudine (Cimduo). In October 2019, the US Food and Drug Administration (FDA) approved the combination of emtricitabine and tenofovir alafenamide (Descovy) to be used as PrEP in addition to Truvada, which provides similar levels of protection. In December 2021, the FDA approved cabotegravir (Apretude), which is an injectable form of PrEP manufactured by ViiV, a pharmaceutical company that specializes in HIV drugs. Regulators believe it will improve medication adherence because it only has to be taken once every two months, and will also widen adoption as it eliminates the need to hide pills or pharmacy visits for discretion."@en . . . . . . "Profilaktyka przedekspozycyjna HIV (ang. pre-exposure prophylaxis, PrEP) \u2013 metoda zapobiegania rozprzestrzeniania si\u0119 czynnika chorobotw\u00F3rczego w\u015Br\u00F3d ludzi nienara\u017Conych jeszcze na kontakt z patogenem. Najcz\u0119\u015Bciej u\u017Cywa si\u0119 tego okre\u015Blenia w profilaktyce wirusa HIV."@pl . . "\uB178\uCD9C\uC804 \uC608\uBC29\uC694\uBC95(Pre-exposure prophylaxis, PrEP)\uB294 \uC9C8\uBCD1 \uC720\uBC1C \uBB3C\uC9C8(\uC77C\uBC18\uC801\uC73C\uB85C \uBC14\uC774\uB7EC\uC2A4)\uC5D0 \uC544\uC9C1 \uB178\uCD9C\uB418\uC9C0 \uC54A\uC740 \uC0AC\uB78C\uB4E4\uC758 \uC9C8\uBCD1 \uD655\uC0B0\uC744 \uC608\uBC29\uD558\uAE30 \uC704\uD574 \uC57D\uBB3C\uC744 \uC0AC\uC6A9\uD558\uB294 \uAC83\uC744 \uC758\uBBF8\uD55C\uB2E4. \uC989, \uC77C\uBC18\uC801\uC73C\uB85C \uD56D\uBC14\uC774\uB7EC\uC2A4 \uC57D\uBB3C\uC744 HIV/AIDS \uC608\uBC29\uC744 \uC704\uD574 \uC0AC\uC6A9\uD558\uB294 \uAC83\uC744 \uC758\uBBF8\uD55C\uB2E4. PrEP\uB294 HIV \uC608\uBC29\uC804\uB7B5 \uC911 \uD558\uB098\uB85C \uC131\uC801(sexually)\uC73C\uB85C \uD65C\uB3D9\uC801\uC778 \uC131\uC778, \uC8FC\uC0AC \uC57D\uBB3C \uC0AC\uC6A9\uC5D0 \uAD00\uC5EC\uD558\uB294 \uC0AC\uB78C\uB4E4(\uC57D\uBB3C \uC8FC\uC0AC \uCC38\uC870), \uD55C \uD30C\uD2B8\uB108\uB9CC HIV\uC5D0 \uAC10\uC5FC\uB418\uACE0 \uB2E4\uB978 \uD30C\uD2B8\uB108\uB294 \uAC10\uC5FC\uB418\uC9C0 \uC54A\uC740 \uD608\uCCAD\uD559\uC801\uC73C\uB85C \uBD88\uC77C\uCE58\uD558\uB294 \uC0AC\uB78C\uC744 \uD3EC\uD568\uD558\uC5EC HIV \uC74C\uC131\uC774\uC9C0\uB9CC HIV\uC5D0 \uAC78\uB9B4 \uC704\uD5D8\uC774 \uB192\uC740 \uC0AC\uB78C\uB4E4\uC744 \uC704\uD55C \uAC83\uC774\uB2E4."@ko . . . . "Profilassi pre-esposizione"@it . . . . . . . . . . . . . . . . "Profilaktyka przedekspozycyjna HIV"@pl . "La profilassi pre-esposizione (abbreviata in PrEP) \u00E8 una strategia di profilassi, che consiste nell'uso di farmaci per prevenire una malattia in persone che non sono ancora state esposte all'agente che la causa. Il termine si riferisce all'uso di farmaci antiretrovirali come strategia per la prevenzione dell'HIV/AIDS. La PrEP \u00E8 una delle numerose strategie di prevenzione dell'HIV per le persone che sono negative all'HIV ma che hanno anche un rischio superiore alla media di contrarre l'HIV, compresi gli adulti sessualmente attivi a maggior rischio di HIV, persone che si dedicano all'uso di droghe per via iniettiva e coppie sessualmente attive sierodiscordanti (un partner HIV sieropositivo e l'altro no)."@it . . . "Is \u00E9ard at\u00E1 i gceist leis an gcl\u00E1r PrEP n\u00F3 pr\u00F3ifiolacsas r\u00E9amhnochta (n\u00F3 Truvada) n\u00E1 \u00FAs\u00E1id r\u00E9amhchoisctheach a bhaint as c\u00F3gais frithv\u00EDreasacha chun ionfhabht\u00FA VEID a chosc."@ga . . . . . . . . . . "Profilaxia pr\u00E9-exposi\u00E7\u00E3o (PrPE ou em sua vers\u00E3o inglesa PrEP) \u00E9 qualquer procedimento m\u00E9dico ou sanit\u00E1rio usado antes da exposi\u00E7\u00E3o a um pat\u00F3geno capaz de provocar uma doen\u00E7a, com o prop\u00F3sito de prevenir, e n\u00E3o tratar ou curar, essa doen\u00E7a; especialmente referido ao de VIH. Trata-se de um procedimento opcional para pessoas s\u00E3s HIV-negativas, mas que t\u00EAm um risco substancial, mais alto que a m\u00E9dia, de contrair uma infec\u00E7\u00E3o por HIV."@pt . "Profilaxi preexposici\u00F3 per al VIH"@ca . "\u041F\u0435\u0440\u0435\u0434\u0435\u043A\u0441\u043F\u043E\u0437\u0438\u0446\u0456\u0439\u043D\u0430 \u0430\u0431\u043E \u0434\u043E\u043A\u043E\u043D\u0442\u0430\u043A\u0442\u043D\u0430 \u043F\u0440\u043E\u0444\u0456\u043B\u0430\u043A\u0442\u0438\u043A\u0430 \u0412\u0406\u041B, \u041F\u0440\u0415\u041F \u0430\u0431\u043E \u0414\u041A\u041F (\u0430\u043D\u0433\u043B. Pre-exposure prophylaxis, PrEP) \u2014 \u043F\u0440\u043E\u0444\u0456\u043B\u0430\u043A\u0442\u0438\u0447\u043D\u0438\u0439 \u043F\u0440\u0438\u0439\u043E\u043C \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0456\u0432 \u0432\u0438\u0441\u043E\u043A\u043E\u0430\u043A\u0442\u0438\u0432\u043D\u043E\u0457 \u0430\u043D\u0442\u0438\u0440\u0435\u0442\u0440\u043E\u0432\u0456\u0440\u0443\u0441\u043D\u043E\u0457 \u0442\u0435\u0440\u0430\u043F\u0456\u0457 \u043B\u044E\u0434\u044C\u043C\u0438, \u044F\u043A\u0456 \u043D\u0435 \u043C\u0430\u044E\u0442\u044C \u0412\u0406\u041B, \u0437 \u043C\u0435\u0442\u043E\u044E \u0437\u043D\u0438\u0436\u0435\u043D\u043D\u044F \u0440\u0438\u0437\u0438\u043A\u0443 \u043C\u043E\u0436\u043B\u0438\u0432\u043E\u0433\u043E \u0437\u0430\u0440\u0430\u0436\u0435\u043D\u043D\u044F \u0446\u0438\u043C \u0432\u0456\u0440\u0443\u0441\u043E\u043C. \u041F\u0440\u043E\u0432\u0435\u0434\u0435\u043D\u0456 \u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0456 \u0434\u043E\u0441\u043B\u0456\u0434\u0436\u0435\u043D\u043D\u044F \u043F\u043E\u043A\u0430\u0437\u0430\u043B\u0438, \u0449\u043E \u0432\u0438\u043A\u043E\u0440\u0438\u0441\u0442\u0430\u043D\u043D\u044F \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0456\u0432 \u0432\u0438\u0441\u043E\u043A\u043E\u0430\u043A\u0442\u0438\u0432\u043D\u043E\u0457 \u0430\u043D\u0442\u0438\u0440\u0435\u0442\u0440\u043E\u0432\u0456\u0440\u0443\u0441\u043D\u043E\u0457 \u0442\u0435\u0440\u0430\u043F\u0456\u0457 \u0434\u043B\u044F \u043F\u0440\u043E\u0444\u0456\u043B\u0430\u043A\u0442\u0438\u043A\u0438 \u0412\u0406\u041B \u0445\u043E\u0447\u0430 \u0456 \u0437\u043D\u0430\u0447\u043D\u043E \u0437\u043D\u0438\u0436\u0443\u0454 \u0440\u0438\u0437\u0438\u043A \u0437\u0430\u0440\u0430\u0436\u0435\u043D\u043D\u044F, \u0430\u043B\u0435 \u043D\u0435 \u0434\u0430\u044E\u0442\u044C \u043F\u043E\u0432\u043D\u043E\u0457 \u0433\u0430\u0440\u0430\u043D\u0442\u0456\u0457 \u0437\u0430\u0445\u0438\u0441\u0442\u0443 \u0432\u0456\u0434 \u0412\u0406\u041B. \u0404\u0434\u0438\u043D\u0438\u043C \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u043E\u043C, \u0434\u043E\u0437\u0432\u043E\u043B\u0435\u043D\u0438\u043C \u0434\u043B\u044F \u043F\u0440\u0435\u0434\u0435\u043A\u0441\u043F\u043E\u0437\u0438\u0446\u0456\u0439\u043D\u043E\u0457 \u043F\u0440\u043E\u0444\u0456\u043B\u0430\u043A\u0442\u0438\u043A\u0438 \u0412\u0406\u041B, \u0432 \u0434\u0430\u043D\u0438\u0439 \u0447\u0430\u0441 \u0454 Truvada."@uk . . "Pre-exposure prophylaxis"@en . . . . . . . . . "Profilaksis prapajanan (bahasa Inggris: Pre-exposure prophylaxis, disingkat PrEP) adalah penggunaan obat-obatan untuk mencegah penyakit pada orang yang belum pernah terpapar dengan agen penyebab penyakit tersebut. Istilah ini khususnya mengacu kepada penggunaan obat-obatan antiretroviral sebagai strategi . PrEP adalah salah satu strategi pencegahan HIV untuk mereka yang belum mengidap HIV, tetapi menghadapi risiko tertular HIV yang tinggi, seperti orang dewasa yang aktif secara seksual, pemakai jarum suntik untuk narkoba, dan pasangan yang (salah satu pasangan mengidap HIV, yang lainnya tidak). Saat ini, satu-satunya obat yang disarankan oleh organisasi kesehatan untuk PrEP HIV/AIDS adalah Truvada, yang merupakan merk dagang dari kombinasi tenofovir/emtrisitabin. Pasien PrEP mengonsumsi Truvada setiap hari dan juga harus pergi ke dokter paling tidak setiap tiga bulan untuk melakukan cek HIV. Jika digunakan dengan benar, PrEP sangat efektif dalam mengurangi risiko tertular HIV. PrEP dibuat dengan maksud untuk digunakan bersamaan dengan strategi yang mengurangi risiko lainnya, seperti penggunaan kondom, karena orang yang mengonsumsi PrEP masih menghadapi risiko tertular HIV, terutama mereka yang tidak mengonsumsinya secara rutin, dan juga karena orang yang memakai PrEP masih menghadapi risiko terkena penyakit menular seksual lainnya."@in . . . . . . . . "Profilaktyka przedekspozycyjna HIV (ang. pre-exposure prophylaxis, PrEP) \u2013 metoda zapobiegania rozprzestrzeniania si\u0119 czynnika chorobotw\u00F3rczego w\u015Br\u00F3d ludzi nienara\u017Conych jeszcze na kontakt z patogenem. Najcz\u0119\u015Bciej u\u017Cywa si\u0119 tego okre\u015Blenia w profilaktyce wirusa HIV."@pl . . . . . . . . . . . . "Die HIV-Pr\u00E4expositionsprophylaxe (PrEP) bezeichnet die Einnahme systemisch wirksamer antiviraler Medikamente durch HIV-negative Personen in Erwartung einer potenziellen HIV-Exposition aus bekannten oder unbekannten Quellen, um die HIV-\u00DCbertragung zu verhindern. Die Weltgesundheitsorganisation empfiehlt die PrEP seit September 2019 \u201Eals zus\u00E4tzliche Pr\u00E4ventionsm\u00F6glichkeit f\u00FCr Menschen mit einem erheblichen HIV-Infektionsrisiko als Teil von kombinierten HIV-Pr\u00E4ventionsans\u00E4tzen\u201C. Zur PrEP sind in der Europ\u00E4ischen Union seit 2016 Kombinationspr\u00E4perate mit den Wirkstoffen Emtricitabin und Tenofovir zugelassen. Die Pr\u00E4expositionsprophylaxe ist eine von mehreren Pr\u00E4ventionsma\u00DFnahmen gegen HIV neben beispielsweise Kondomen, einer antiretroviralen Therapie und der HIV-Postexpositionsprophylaxe. Im G"@de . . . . . . "\u03A0\u03C1\u03BF\u03C6\u03CD\u03BB\u03B1\u03BE\u03B7 \u03C0\u03C1\u03B9\u03BD \u03B1\u03C0\u03CC \u03C4\u03B7\u03BD \u03AD\u03BA\u03B8\u03B5\u03C3\u03B7 - PrEP"@el . . . "Profilaxis preexposici\u00F3n para el VIH"@es . "\u66B4\u9732\u524D\u9884\u9632"@zh . . . . "\uB178\uCD9C\uC804 \uC608\uBC29\uC694\uBC95"@ko . . . . "\u66B4\u9732\u524D\u4E88\u9632\u6295\u4E0E\uFF08\u3070\u304F\u308D\u305C\u3093\u3088\u307C\u3046\u3068\u3046\u3084\u304F\u3001\u82F1\u8A9E: Pre-exposure prophylaxis\u3001\u7565\u79F0:PrEP\uFF09\u306F\u3001\u307E\u3060\u75BE\u60A3\u3092\u5F15\u304D\u8D77\u3053\u3059\u7269\u8CEA\u306B\u66B4\u9732\u3055\u308C\u3066\u3044\u306A\u3044\u4EBA\u3005\u306E\u611F\u67D3\u3092\u4E88\u9632\u3059\u308B\u305F\u3081\u306E\u85AC\u306E\u4F7F\u7528\u3067\u3042\u308B\u3002\u3053\u306E\u7528\u8A9E\u306F\u901A\u5E38\u3001\u5F8C\u5929\u6027\u514D\u75AB\u4E0D\u5168\u75C7\u5019\u7FA4\uFF08HIV/AIDS\uFF09\u306E\u4E88\u9632\u306E\u305F\u3081\u306E\u6297HIV\u85AC\u3092\u610F\u5473\u3059\u308B\u3002"@ja . "PrEP, afkorting van Pre-Expositie Profylaxe (of vaak ook Engels pre-exposure prophylaxis), is het gebruik van hiv-remmers om een hiv-infectie te voorkomen. De naam verwijst naar preventie (profylaxe) v\u00F3\u00F3r blootstelling aan een mogelijk risico (pre-expositie). Deze preventiemethode is bedoeld voor mensen die geen hiv hebben, maar wel een verhoogd risico lopen."@nl . . "\u0397 \u03C0\u03C1\u03BF\u03C6\u03CD\u03BB\u03B1\u03BE\u03B7 \u03C0\u03C1\u03B9\u03BD \u03B1\u03C0\u03CC \u03C4\u03B7\u03BD \u03AD\u03BA\u03B8\u03B5\u03C3\u03B7 ( PrEP ) \u03B5\u03AF\u03BD\u03B1\u03B9 \u03C6\u03AC\u03C1\u03BC\u03B1\u03BA\u03B1 \u03C0\u03BF\u03C5 \u03C7\u03C1\u03B7\u03C3\u03B9\u03BC\u03BF\u03C0\u03BF\u03B9\u03BF\u03CD\u03BD\u03C4\u03B1\u03B9 \u03B3\u03B9\u03B1 \u03C4\u03B7\u03BD \u03C0\u03C1\u03CC\u03BB\u03B7\u03C8\u03B7 \u03C4\u03B7\u03C2 \u03B5\u03BE\u03AC\u03C0\u03BB\u03C9\u03C3\u03B7\u03C2 \u03C4\u03B7\u03C2 \u03BD\u03CC\u03C3\u03BF\u03C5 \u03C4\u03BF\u03C5 HIV \u03C3\u03B5 \u03AC\u03C4\u03BF\u03BC\u03B1 \u03C0\u03BF\u03C5 \u03B4\u03B5\u03BD \u03AD\u03C7\u03BF\u03C5\u03BD \u03B1\u03BA\u03CC\u03BC\u03B7 \u03B5\u03BA\u03C4\u03B5\u03B8\u03B5\u03AF \u03C3\u03B5 \u03C0\u03B1\u03C1\u03AC\u03B3\u03BF\u03BD\u03C4\u03B1 \u03C0\u03BF\u03C5 \u03C0\u03C1\u03BF\u03BA\u03B1\u03BB\u03B5\u03AF \u03B1\u03C3\u03B8\u03AD\u03BD\u03B5\u03B9\u03B1, \u03C3\u03C5\u03BD\u03AE\u03B8\u03C9\u03C2 \u03AD\u03BD\u03B1\u03BD \u03B9\u03CC . \u039F \u03CC\u03C1\u03BF\u03C2 \u03B1\u03BD\u03B1\u03C6\u03AD\u03C1\u03B5\u03C4\u03B1\u03B9 \u03C3\u03C5\u03BD\u03AE\u03B8\u03C9\u03C2 \u03C3\u03C4\u03B7\u03BD \u03B5\u03B9\u03B4\u03B9\u03BA\u03AE \u03C7\u03C1\u03AE\u03C3\u03B7 \u03B1\u03BD\u03C4\u03B9\u03B9\u03BA\u03CE\u03BD \u03C6\u03B1\u03C1\u03BC\u03AC\u03BA\u03C9\u03BD \u03C9\u03C2 \u03C3\u03C4\u03C1\u03B1\u03C4\u03B7\u03B3\u03B9\u03BA\u03AE \u03B3\u03B9\u03B1 \u03C4\u03B7\u03BD \u03C0\u03C1\u03CC\u03BB\u03B7\u03C8\u03B7 \u03C4\u03BF\u03C5 HIV / AIDS . \u03A4\u03BF PrEP \u03B5\u03AF\u03BD\u03B1\u03B9 \u03BC\u03AF\u03B1 \u03B1\u03C0\u03CC \u03C4\u03B9\u03C2 \u03C0\u03BF\u03BB\u03BB\u03AD\u03C2 \u03C3\u03C4\u03C1\u03B1\u03C4\u03B7\u03B3\u03B9\u03BA\u03AD\u03C2 \u03C0\u03C1\u03CC\u03BB\u03B7\u03C8\u03B7\u03C2 \u03C4\u03BF\u03C5 HIV \u03B3\u03B9\u03B1 \u03AC\u03C4\u03BF\u03BC\u03B1 \u03C0\u03BF\u03C5 \u03B5\u03AF\u03BD\u03B1\u03B9 \u03B1\u03C1\u03BD\u03B7\u03C4\u03B9\u03BA\u03AC \u03C3\u03C4\u03BF\u03BD HIV, \u03B1\u03BB\u03BB\u03AC \u03AD\u03C7\u03BF\u03C5\u03BD \u03B5\u03C0\u03AF\u03C3\u03B7\u03C2 \u03C5\u03C8\u03B7\u03BB\u03CC\u03C4\u03B5\u03C1\u03BF \u03BA\u03AF\u03BD\u03B4\u03C5\u03BD\u03BF \u03BD\u03B1 \u03C0\u03C1\u03BF\u03C3\u03B2\u03BB\u03B7\u03B8\u03BF\u03CD\u03BD \u03B1\u03C0\u03CC \u03C4\u03BF\u03BD \u03B9\u03CC HIV, \u03C3\u03C5\u03BC\u03C0\u03B5\u03C1\u03B9\u03BB\u03B1\u03BC\u03B2\u03B1\u03BD\u03BF\u03BC\u03AD\u03BD\u03C9\u03BD \u03C4\u03C9\u03BD \u03C3\u03B5\u03BE\u03BF\u03C5\u03B1\u03BB\u03B9\u03BA\u03AC \u03B5\u03BD\u03B5\u03C1\u03B3\u03CE\u03BD \u03B5\u03BD\u03B7\u03BB\u03AF\u03BA\u03C9\u03BD \u03BC\u03B5 \u03B1\u03C5\u03BE\u03B7\u03BC\u03AD\u03BD\u03BF \u03BA\u03AF\u03BD\u03B4\u03C5\u03BD\u03BF HIV, \u03C4\u03C9\u03BD \u03B1\u03C4\u03CC\u03BC\u03C9\u03BD \u03C0\u03BF\u03C5 \u03B5\u03BC\u03C0\u03BB\u03AD\u03BA\u03BF\u03BD\u03C4\u03B1\u03B9 \u03C3\u03C4\u03B7 \u03C7\u03C1\u03AE\u03C3\u03B7 \u03B5\u03BD\u03AD\u03C3\u03B9\u03BC\u03C9\u03BD \u03BD\u03B1\u03C1\u03BA\u03C9\u03C4\u03B9\u03BA\u03CE\u03BD (\u03B2\u03BB. \u0388\u03BD\u03B5\u03C3\u03B7 \u03BD\u03B1\u03C1\u03BA\u03C9\u03C4\u03B9\u03BA\u03CE\u03BD ), \u03BA\u03B1\u03B9 \u03C3\u03B5\u03C1\u03BF\u03B4\u03B9\u03B1\u03C6\u03BF\u03C1\u03B9\u03BA\u03AC \u03C3\u03B5\u03BE\u03BF\u03C5\u03B1\u03BB\u03B9\u03BA\u03AC \u03B5\u03BD\u03B5\u03C1\u03B3\u03AC \u03B6\u03B5\u03C5\u03B3\u03AC\u03C1\u03B9\u03B1 \u038C\u03C4\u03B1\u03BD \u03C7\u03C1\u03B7\u03C3\u03B9\u03BC\u03BF\u03C0\u03BF\u03B9\u03B5\u03AF\u03C4\u03B1\u03B9 \u03C3\u03CD\u03BC\u03C6\u03C9\u03BD\u03B1 \u03BC\u03B5 \u03C4\u03B9\u03C2 \u03BF\u03B4\u03B7\u03B3\u03AF\u03B5\u03C2, \u03C4\u03BF PrEP \u03AD\u03C7\u03B5\u03B9 \u03B1\u03C0\u03BF\u03B4\u03B5\u03B9\u03C7\u03B8\u03B5\u03AF \u03B5\u03BE\u03B1\u03B9\u03C1\u03B5\u03C4\u03B9\u03BA\u03AC \u03B1\u03C0\u03BF\u03C4\u03B5\u03BB\u03B5\u03C3\u03BC\u03B1\u03C4\u03B9\u03BA\u03CC, \u03BC\u03B5\u03B9\u03CE\u03BD\u03BF\u03BD\u03C4\u03B1\u03C2 \u03C4\u03BF\u03BD \u03BA\u03AF\u03BD\u03B4\u03C5\u03BD\u03BF \u03B1\u03C0\u03CC\u03BA\u03C4\u03B7\u03C3\u03B7\u03C2 HIV \u03AD\u03C9\u03C2 99%. \u03A9\u03C2 \u03C4\u03B9\u03C2 2019 , \u03BF \u03A0\u03B1\u03B3\u03BA\u03CC\u03C3\u03BC\u03B9\u03BF\u03C2 \u039F\u03C1\u03B3\u03B1\u03BD\u03B9\u03C3\u03BC\u03CC\u03C2 \u03A5\u03B3\u03B5\u03AF\u03B1\u03C2 (\u03A0\u039F\u03A5) \u03C0\u03C1\u03BF\u03C4\u03B5\u03AF\u03BD\u03B5\u03B9 \u03B4\u03CD\u03BF \u03C3\u03C5\u03BD\u03B4\u03C5\u03B1\u03C3\u03BC\u03BF\u03CD\u03C2 \u03C6\u03B1\u03C1\u03BC\u03AC\u03BA\u03C9\u03BD \u03B3\u03B9\u03B1 \u03C7\u03C1\u03AE\u03C3\u03B7 \u03C9\u03C2 PrEP \u03B3\u03B9\u03B1 HIV: \u03BF \u03C3\u03C5\u03BD\u03B4\u03C5\u03B1\u03C3\u03BC\u03CC\u03C2 tenofovir disoproxil \u03BA\u03B1\u03B9 emtricitabine (Truvada) \u03AE \u03BF \u03C3\u03C5\u03BD\u03B4\u03C5\u03B1\u03C3\u03BC\u03CC\u03C2 tenofovir disoproxil \u03BA\u03B1\u03B9 lamivudine (Cimduo). \u03A4\u03BF\u03BD \u039F\u03BA\u03C4\u03CE\u03B2\u03C1\u03B9\u03BF \u03C4\u03BF\u03C5 2019, \u03B7 \u0391\u03BC\u03B5\u03C1\u03B9\u03BA\u03B1\u03BD\u03B9\u03BA\u03AE \u03A5\u03C0\u03B7\u03C1\u03B5\u03C3\u03AF\u03B1 \u03A4\u03C1\u03BF\u03C6\u03AF\u03BC\u03C9\u03BD \u03BA\u03B1\u03B9 \u03A6\u03B1\u03C1\u03BC\u03AC\u03BA\u03C9\u03BD (FDA) \u03B5\u03BD\u03AD\u03BA\u03C1\u03B9\u03BD\u03B5 \u03C4\u03BF \u03C3\u03C5\u03BD\u03B4\u03C5\u03B1\u03C3\u03BC\u03CC emtricitabine \u03BA\u03B1\u03B9 tenofovir alafenamide (Descovy) \u03B3\u03B9\u03B1 \u03C7\u03C1\u03AE\u03C3\u03B7 \u03C9\u03C2 PrEP \u03BC\u03B1\u03B6\u03AF \u03BC\u03B5 \u03C4\u03BF Truvada, \u03C4\u03BF \u03BF\u03C0\u03BF\u03AF\u03BF \u03C0\u03B1\u03C1\u03AD\u03C7\u03B5\u03B9 \u03C0\u03B1\u03C1\u03CC\u03BC\u03BF\u03B9\u03B1 \u03B5\u03C0\u03AF\u03C0\u03B5\u03B4\u03B1 \u03C0\u03C1\u03BF\u03C3\u03C4\u03B1\u03C3\u03AF\u03B1\u03C2."@el . "Die HIV-Pr\u00E4expositionsprophylaxe (PrEP) bezeichnet die Einnahme systemisch wirksamer antiviraler Medikamente durch HIV-negative Personen in Erwartung einer potenziellen HIV-Exposition aus bekannten oder unbekannten Quellen, um die HIV-\u00DCbertragung zu verhindern. Die Weltgesundheitsorganisation empfiehlt die PrEP seit September 2019 \u201Eals zus\u00E4tzliche Pr\u00E4ventionsm\u00F6glichkeit f\u00FCr Menschen mit einem erheblichen HIV-Infektionsrisiko als Teil von kombinierten HIV-Pr\u00E4ventionsans\u00E4tzen\u201C. Zur PrEP sind in der Europ\u00E4ischen Union seit 2016 Kombinationspr\u00E4perate mit den Wirkstoffen Emtricitabin und Tenofovir zugelassen. Die Pr\u00E4expositionsprophylaxe ist eine von mehreren Pr\u00E4ventionsma\u00DFnahmen gegen HIV neben beispielsweise Kondomen, einer antiretroviralen Therapie und der HIV-Postexpositionsprophylaxe. Im Gegensatz zu Kondomen sch\u00FCtzt die PrEP nicht gegen andere sexuell \u00FCbertragbare Erkrankungen."@de . "La prophylaxie pr\u00E9-exposition, abr\u00E9g\u00E9 PrEP (de l'anglais pre-exposure prophylaxis) est un traitement m\u00E9dicamenteux qui emp\u00EAche l'infection par le virus du sida chez des personnes s\u00E9ron\u00E9gatives. Le m\u00E9dicament utilise la combinaison de deux antir\u00E9troviraux tenofovir/emtricitabine. La PrEP est un des nombreux moyens de pr\u00E9vention contre le virus de l'immunod\u00E9ficience humaine (VIH) utilis\u00E9 par les personnes qui ont un risque \u00E9lev\u00E9 de contracter le virus. Elle s'adresse notamment aux personnes ayant des partenaires sexuels multiples (notamment les prostitu\u00E9(e)s et les acteurs ou actrices porno), aux personnes qui s'injectent de la drogue ainsi qu'aux couples s\u00E9rodiff\u00E9rents actifs sexuellement dont le partenaire s\u00E9ropositif a une charge virale non stabilis\u00E9e. Initialement, seul le m\u00E9dicament Truvada commercialis\u00E9 par Gilead Sciences pouvait \u00EAtre utilis\u00E9 dans le cadre de la PrEP. Le traitement doit \u00E9galement faire l'objet d'un suivi m\u00E9dical r\u00E9gulier. Depuis juillet 2017 en France et depuis juillet 2018 dans toute l\u2019Union europ\u00E9enne, plusieurs versions g\u00E9n\u00E9riques sont \u00E9galement autoris\u00E9es, permettant ainsi de r\u00E9duire significativement le co\u00FBt des traitements."@fr . . . "\u0648\u0642\u0627\u064A\u0629 \u0642\u0628\u0644 \u0627\u0644\u062A\u0639\u0631\u0636"@ar . . . . . . . . . "5295343"^^ . "Profilaxia pr\u00E9-exposi\u00E7\u00E3o"@pt . . . . . . . . "\u66B4\u9732\u524D\u9884\u9632\uFF08\u82F1\u8A9E\uFF1APre-exposure prophylaxis\uFF0C\u7F29\u5199\u4E3APrEP\uFF09\uFF0C\u53C8\u8BD1\u4F5C\u201C\u63A5\u89E6\u524D\u9884\u9632\u201D\uFF0C\u662F\u6307\u5728\u63A5\u89E6\u75C5\u539F\u4F53\u4E4B\u524D\u7528\u836F\u9884\u9632\u75BE\u75C5\u7684\u63AA\u65BD\uFF0C\u7279\u6307\u5728\u63A5\u89E6\u75C5\u539F\u4F53\u4E4B\u524D\u670D\u7528\u6297\u75C5\u6BD2\u836F\u7269\u9884\u9632\u827E\u6ECB\u75C5\u6BD2/\u827E\u6ECB\u75C5\u7684\u624B\u6BB5\uFF0C\u80FD\u6709\u6548\u964D\u4F4E\u9AD8\u5371\u4EBA\u7FA4\u611F\u67D3\u827E\u6ECB\u75C5\u6BD2\u7684\u98CE\u9669\u3002 \u76EE\u524D\u552F\u4E00\u6709\u5065\u5EB7\u7EC4\u7EC7\u63A8\u8350\u7684PrEP\u836F\u7269\u662F\u6069\u66F2\u4ED6\u6EE8/\u66FF\u8BFA\u798F\u97E6\u3002\u5176\u7531\u5409\u5229\u5FB7\u79D1\u5B78\u516C\u53F8\u5F00\u53D1\uFF0C\u542B\u6709\u66FF\u8AFE\u798F\u97CB\u548C\u6069\u66F2\u4ED6\u6FF1\u4E24\u79CD\u836F\u54C1\u3002\u7F8E\u570B\u75BE\u75C5\u63A7\u5236\u8207\u9810\u9632\u4E2D\u5FC3\u79F0\uFF0C\u201CPrEP\u662F\u4E00\u79CD\u6709\u6548\u7684HIV\u9632\u6CBB\u624B\u6BB5\u3002\u5F53\u7ED3\u5408\u5B89\u5168\u5957\u7B49\u9632\u6CBB\u65B9\u6CD5\u4E00\u540C\u4F7F\u7528\uFF0C\u5176\u4FDD\u62A4\u6548\u679C\u66F4\u4F73\u3002\u4E0D\u8FC7PrEP\u7684\u4F7F\u7528\u8005\u5FC5\u987B\u6BCF\u65E5\u670D\u7528\u836F\u7269\uFF0C\u5E76\u6BCF\u4E09\u4E2A\u6708\u62DC\u8BBF\u533B\u751F\uFF0C\u4EE5\u4FBF\u8DDF\u8E2A\u6CBB\u7597\u3002\u201D\u4E16\u754C\u885B\u751F\u7D44\u7E54\uFF08WHO\uFF09\u5EFA\u8B70\u5728\u65B0\u611F\u67D3\u4EBA\u6578\u5927\u65BC\u6BCF\u767E\u4EBA\u5E743\u4EBA\u4EE5\u4E0A\u7684\u65CF\u7FA4\uFF0C\u61C9\u8A72\u5C07PrEP\u4F5C\u70BA\u9810\u9632\u63AA\u65BD\u4E4B\u4E00\u3002 \u53F0\u6E7E\u65BC2016\u5E74\u3001\u4E2D\u56FD\u5927\u9646\u65BC2020\u5E74\u6838\u51C6\u8212\u53D1\u6CF0\u4F5C\u70BAPrEP\u4F7F\u7528\u3002"@zh . . . "1121706582"^^ . . "\u041F\u0440\u0435\u0434\u044D\u043A\u0441\u043F\u043E\u0437\u0438\u0446\u0438\u043E\u043D\u043D\u0430\u044F \u0438\u043B\u0438 \u0434\u043E\u043A\u043E\u043D\u0442\u0430\u043A\u0442\u043D\u0430\u044F \u043F\u0440\u043E\u0444\u0438\u043B\u0430\u043A\u0442\u0438\u043A\u0430 \u0412\u0418\u0427, \u041F\u0440\u0415\u041F (\u041F\u0440\u042D\u041F \u0432 \u043D\u0435\u043A\u043E\u0442\u043E\u0440\u044B\u0445 \u0440\u0443\u0441\u0441\u043A\u043E\u044F\u0437\u044B\u0447\u043D\u044B\u0445 \u0438\u0441\u0442\u043E\u0447\u043D\u0438\u043A\u0430\u0445) \u0438\u043B\u0438 \u0414\u041A\u041F (\u0430\u043D\u0433\u043B. Pre-exposure prophylaxis, PrEP) \u2014 \u043F\u0440\u043E\u0444\u0438\u043B\u0430\u043A\u0442\u0438\u0447\u0435\u0441\u043A\u0438\u0439 \u043F\u0440\u0438\u0451\u043C \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u043E\u0432 \u0432\u044B\u0441\u043E\u043A\u043E\u0430\u043A\u0442\u0438\u0432\u043D\u043E\u0439 \u0430\u043D\u0442\u0438\u0440\u0435\u0442\u0440\u043E\u0432\u0438\u0440\u0443\u0441\u043D\u043E\u0439 \u0442\u0435\u0440\u0430\u043F\u0438\u0438 \u043B\u044E\u0434\u044C\u043C\u0438, \u043D\u0435 \u0438\u043C\u0435\u044E\u0449\u0438\u043C\u0438 \u0412\u0418\u0427, \u0441 \u0446\u0435\u043B\u044C\u044E \u0441\u043D\u0438\u0436\u0435\u043D\u0438\u044F \u0440\u0438\u0441\u043A\u0430 \u0432\u043E\u0437\u043C\u043E\u0436\u043D\u043E\u0433\u043E \u0437\u0430\u0440\u0430\u0436\u0435\u043D\u0438\u044F \u044D\u0442\u0438\u043C \u0432\u0438\u0440\u0443\u0441\u043E\u043C."@ru . . "La profilaxis preexposici\u00F3n (acr\u00F3nimo PPrE o en su versi\u00F3n inglesa PrEP) se refiere a la administraci\u00F3n de f\u00E1rmacos antirretrovirales de forma continuada a personas seronegativas para VIH con riesgo sustancial, superior al promedio, de contraer una infecci\u00F3n por VIH.\u200B Si una persona est\u00E1 tomando PPrE y se expone al semen, l\u00EDquido pre-seminal o fluidos vaginales de una persona con VIH, el medicamento antirretroviral ayuda a prevenir que el virus infecte las c\u00E9lulas del sistema inmunol\u00F3gico y as\u00ED evita que se establezca la infecci\u00F3n por VIH.\u200B En la actualidad, el \u00FAnico f\u00E1rmaco recomendado para la profilaxis preexposici\u00F3n del VIH es Truvada, una combinaci\u00F3n de emtricitabina y tenofovir disoproxil fumarato. Seg\u00FAn los Centros para el Control y Prevenci\u00F3n de Enfermedades la PPrE puede ser una poderosa herramienta de prevenci\u00F3n del VIH al combinarse con condones y otros m\u00E9todos de prevenci\u00F3n para proporcionar una protecci\u00F3n a\u00FAn mayor que cuando se utilizan por separado. Sin embargo, las personas que usan PrEP deben comprometerse a tomar el medicamento todos los d\u00EDas y mantener un seguimiento m\u00E9dico al menos cada 3 meses.\u200B Uno de los ingredientes activos de la preparaci\u00F3n es el fumarato de disoproxilo de tenofovir, que es un an\u00E1logo de nucle\u00F3tido que inhibe de la transcriptasa inversa, bloqueando eficazmente la incorporaci\u00F3n del material gen\u00E9tico del VIH en el genoma del hu\u00E9sped, y por lo tanto, evitando la infecci\u00F3n por VIH.\u200B PPrE est\u00E1 recomendado para el uso combinado con preservativos, de manera que cada m\u00E9todo puede compensar los d\u00E9ficits de eficacia ocasionales del otro.\u200B Existe una divisi\u00F3n social entre el apoyo y la oposici\u00F3n al uso de la profilaxis preexposici\u00F3n como m\u00E9todo de prevenci\u00F3n de la infecci\u00F3n por VIH. En febrero de 2016 se document\u00F3 el primer caso de una persona que, tomando adecuadamente la PPrE, se infect\u00F3 de una cepa multirresistente al tratamiento,\u200B seguido por un segundo caso en octubre del mismo a\u00F1o.\u200B En febrero de 2017 se report\u00F3 el caso de una tercera persona infectada de VIH tomando adecuadamente el tratamiento, siendo el primer caso de adquisici\u00F3n de una cepa sin ninguna resistencia a los f\u00E1rmacos que contiene la PPrE.\u200B Por el momento, las nuevas infecciones derivadas de un uso irregular o espor\u00E1dico de la PPrE no est\u00E1n contabilizadas.\u200B Los actores pornogr\u00E1ficos, que han sido cuestionados en especial los que realizan escenas de sexo barebacking (coloquialmente llamado en espa\u00F1ol \"a pelo\"), est\u00E1n siendo llamados a tomar PPrE y a hacerlo p\u00FAblico, como una manera de fomentar la prevenci\u00F3n del virus.\u200B"@es .